COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 1046: Articles 10451-10460  | Next

GB0139, an inhaled small molecule inhibitor of galectin-3, in COVID-19 pneumonitis: a randomised, controlled, open-label, phase 2a experimental medicine trial of the safety, pharmacokinetics, and potential therapeutic value
Gaughan, E., Sethi, T., Quinn, T., Hirani, N., Mills, A., Bruce, A. M., MacKinnon, A., Aslanis, V., Li, F., O'Connor, R., Parker, R. A., Norrie, J., Dear, J., Akram, A. R., Koch, O., Wang-Jairaj, J., Slack, R. J., Gravelle, L., Lindmark, B., Dhaliwal, K.
10.1101/2021.12.21.21267983 — Posted: 2021-12-21
Spatiotemporal patterns and progression of the Delta variant of COVID-19 and their health intervention linkages in Southeast Asia
Luo, W., Liu, Z., Zhou, Y., Zhao, Y., Li, Y. E., Masrur, A., Yu, M.
10.1101/2021.12.20.21268140 — Posted: 2021-12-21
Immunity acquired by a minority active fraction of the population could explain COVID-19 spread in Greater Buenos Aires (June-November 2020)
Fabricius, G., Borzi, R., Caminos, J., Grigera, T. S.
10.1101/2021.12.21.21267955 — Posted: 2021-12-21
Statistical Forecasting : Third Wave of COVID-19-With an Application to India
Rajeshbhai, S. P., Dhar, S. S., Shalabh, S.
10.1101/2021.12.20.21268150 — Posted: 2021-12-21
A nationwide deep learning pipeline to predict stroke and COVID-19 death in atrial fibrillation
Handy, A., Wood, A., Sudlow, C., Tomlinson, C., Kee, F., Thygesen, J. H., Mamouei, M., Sofat, R., Dobson, R., Ip, H. Y., Denaxas, S., CVD-COVID-UK Consortium
10.1101/2021.12.20.21268113 — Posted: 2021-12-21
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations
Jacobsen, H., Strengert, M., Maass, H., Ynga Durand, M. A., Kessel, B., Harries, M., Rand, U., Abassi, L., Kim, Y., Lueddecke, T., Hernandez, P., Ortmann, J., Heise, J.-K., Castell, S., Gornyk, D., Gloeckner, S., Melhorn, V., Lange, B., Dulovic, A., Haering, J., Junker, D., Schneiderhan-Marra, N., Poehlmann, S., Hoffmann, M., Krause, G., Cicin-Sain, L.
10.1101/2021.12.21.21267898 — Posted: 2021-12-21
VaxiMap: optimal delivery of vaccinations for housebound patients
Kirk, T. F., Barker, A. J., Bodossian, A., Staruch, R.
10.1101/2021.12.20.21267978 — Posted: 2021-12-21
Economic burden and catastrophic health expenditure associated with COVID-19 hospitalisations in Kerala, South India
Thomas, R., Jacob, Q. M., Eliza, S. R., Mini, M., Jose, J., A, S.
10.1101/2021.12.20.21268081 — Posted: 2021-12-21
Variability in physical inactivity responses of university students during COVID-19 pandemic: A monitoring of daily step counts using a smartphone application
Konda, S., Ogasawara, I., Fujita, K., Aoyama, C., Yokoyama, T., Magome, T., Yulong, C., Hashizume, K., Matsuo, T., Nakata, K.
10.1101/2021.12.21.21268155 — Posted: 2021-12-21
Field evaluation of Rapid SARS-Cov2 Antigen screening test on self-collected deep throat saliva samples in Malaysia
Mohamad Noordin, N., Lim, C. L., Lim, Z.-z., Lim, T. O.
10.1101/2021.12.20.21268141 — Posted: 2021-12-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).